Loading company…
San Francisco biotech developing targeted cancer therapies using proprietary drug delivery and formulation technologies.
Onconetics Pharmaceuticals, Inc. was founded in 2016 in San Francisco, US, and develops targeted cancer therapies using drug delivery and formulation technologies. Luke Gruenert is CEO and founder. In September 2017 the company raised seed funding from IndieBio and SOSV, its first investment round, and it plans to launch new cancer therapy products and enter North American and European markets.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in